论文部分内容阅读
目的探讨脑萎缩老年患者血清超敏C反应蛋白(hs-CRP)水平的变化及其临床意义。方法采用免疫透射比浊法测定31名经CT证实为没有脑萎缩的老年健康者(对照组)和60例脑萎缩老年患者血清hs-CRP值。结果患有脑萎缩(cerebralatrophy)的老年患者血清hs-CRP水平明显高于对照组(P<0.05)。结论hs-CRP可以作为评价老年患者脑萎缩病情严重程度和判断预后的一个有效指标。
Objective To investigate the changes of serum hs-CRP in elderly patients with brain atrophy and its clinical significance. Methods Immunostaining turbidimetry was used to determine the serum hs-CRP levels in 31 elderly healthy people (control group) without brain atrophy and 60 elderly patients with brain atrophy. Results The level of hs-CRP in the elderly patients with cerebralatrophy was significantly higher than that in the control group (P <0.05). Conclusion hs-CRP can be used as an effective indicator to evaluate the severity of brain atrophy and prognosis in elderly patients.